Primary antifungal prophylaxis in hematopoietic stem cell transplant recipients: clinical implications of recent

Kieren A Marr1

  • 1Division of Infectious Diseases, Oregon Health and Science University, Portland, Oregon 97239, USA. marrki@ohsu.edu

Abstract

Insights

New mold-active azole antifungal drugs show promise in preventing invasive fungal infections in hematopoietic stem cell transplant patients. Further research is needed for aerosolized amphotericin B and diagnostic strategies.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Pharmacology

Background:

  • Fungal infections pose a significant risk for poor outcomes in hematopoietic stem cell transplant (HSCT) recipients.
  • Prophylaxis strategies are evolving with the advent of new antifungal agents to combat yeast and mold infections.

Purpose of the Study:

  • To review current antifungal prophylaxis strategies for HSCT recipients.
  • To evaluate the efficacy and safety of new antifungal drugs in preventing fungal infections post-HSCT.

Main Methods:

  • Review of clinical trials evaluating mold-active azoles (posaconazole, voriconazole).
  • Assessment of studies on aerosolized lipid formulations of amphotericin B.
  • Analysis of data on breakthrough infections and drug resistance.

Main Results:

  • Mold-active azoles effectively prevent invasive aspergillosis in hematologic malignancy patients and after allogeneic HSCT.
  • Challenges include optimal dosing, drug interactions, and managing resistant breakthrough infections.
  • Aerosolized amphotericin B shows potential for lung-directed delivery, but long-term safety data is pending.

Conclusions:

  • Mold-active azoles are recommended over fluconazole for prophylaxis in high-risk allogeneic HSCT recipients.
  • Additional research is required for diagnostic tests and aerosolized antifungal delivery methods.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...